Robert Perry

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Elliott Mark S J; Ballard Clive G; Kalaria Rajesh N; Perry Robert; Hortobágyi Tibor; Francis Paul T
Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition.
Chalmers Katy A; Wilcock Gordon K; Vinters Harry V; Perry Elaine K; Perry Robert; Ballard Clive G; Love Seth
Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.
Burton E J; Barber R; Mukaetova-Ladinska E B; Robson J; Perry R H; Jaros E; Kalaria R N; O'Brien J T
Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Robert Perry (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Elliott Mark S J; Ballard Clive G; Kalaria Rajesh N; Perry Robert; Hortobágyi Tibor; Francis Paul T
Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition.
Brain : a journal of neurology 2009;132(Pt 7):1858-65.
2009: Chalmers Katy A; Wilcock Gordon K; Vinters Harry V; Perry Elaine K; Perry Robert; Ballard Clive G; Love Seth
Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.
Journal of neurology 2009;256(5):717-20.
2009: Burton E J; Barber R; Mukaetova-Ladinska E B; Robson J; Perry R H; Jaros E; Kalaria R N; O'Brien J T
Medial temporal lobe atrophy on MRI differentiates Alzheimer's disease from dementia with Lewy bodies and vascular cognitive impairment: a prospective study with pathological verification of diagnosis.
Brain : a journal of neurology 2009;132(Pt 1):195-203.
2008: Tasker Andrea; Ballard Clive G; Joachim Catharine; Warden Donald R; Okello Edward J; Perry Robert H; Khan Nadeem; Smith A David; Lehmann Donald J; Perry Elaine K
Butyrylcholinesterase K variant associated with higher enzyme activity in the temporal cortex of elderly patients.
Neuroscience letters 2008;442(3):297-9.
2008: MacInnes Nicholas; Iravani Mahmoud M; Perry Elaine; Piggott Margaret; Perry Robert; Jenner Peter; Ballard Clive
Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.
Journal of neural transmission (Vienna, Austria : 1996) 2008;115(6):869-78.
2008: Sharp Sally I; Ballard Clive G; Ziabreva Iryna; Piggott Margaret A; Perry Robert H; Perry Elaine K; Aarsland Dag; Ehrt Uwe; Larsen Jan P; Francis Paul T
Cortical serotonin 1A receptor levels are associated with depression in patients with dementia with Lewy bodies and Parkinson's disease dementia.
Dementia and geriatric cognitive disorders 2008;26(4):330-8.
2008: Mukaetova-Ladinska E B; Milne J; Andras A; Abdel-All Z; Cerejeira J; Greally E; Robson J; Jaros E; Perry R; McKeith I G; Brayne C; Xuereb J; Cleghorn A; Doherty J; McIntosh G; Milton I
Alpha- and gamma-synuclein proteins are present in cerebrospinal fluid and are increased in aged subjects with neurodegenerative and vascular changes.
Dementia and geriatric cognitive disorders 2008;26(1):32-42.
2008: Mulugeta Ezra; Molina-Holgado Francisco; Elliott Mark S; Hortobagyi Tibor; Perry Robert; Kalaria Rajesh N; Ballard Clive G; Francis Paul T
Inflammatory mediators in the frontal lobe of patients with mixed and vascular dementia.
Dementia and geriatric cognitive disorders 2008;25(3):278-86.
2007: Piggott Margaret A; Ballard Clive G; Rowan Elise; Holmes Clive; McKeith Ian G; Jaros Evelyn; Perry Robert H; Perry Elaine K
Selective loss of dopamine D2 receptors in temporal cortex in dementia with Lewy bodies, association with cognitive decline.
Synapse (New York, N.Y.) 2007;61(11):903-11.
2007: Walker Zuzana; Jaros Evelyn; Walker Rodney W H; Lee Lean; Costa Durval C; Livingston Gill; Ince Paul G; Perry Robert; McKeith Ian; Katona Cornelius L E
Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy.
Journal of neurology, neurosurgery, and psychiatry 2007;78(11):1176-81.
2007: Ziabreva I; Ballard C; Johnson M; Larsen J P; McKeith I; Perry R; Aarsland D; Perry E
Loss of Musashi1 in Lewy body dementia associated with cholinergic deficit.
Neuropathology and applied neurobiology 2007;33(5):586-90.
2007: Jaros E; Mahad D J; Hudson G; Birchall D; Sawcer S J; Griffiths P G; Sunter J; Compston D A S; Perry R H; Chinnery P F
Primary spinal cord neurodegeneration in Leber hereditary optic neuropathy.
Neurology 2007;69(2):214-6.
2007: Margallo-Lana M L; Moore P B; Kay D W K; Perry R H; Reid B E; Berney T P; Tyrer S P
Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.
Journal of intellectual disability research : JIDR 2007;51(Pt. 6):463-77.
2007: Piggott Margaret A; Ballard Clive G; Dickinson Heather O; McKeith Ian G; Perry Robert H; Perry Elaine K
Thalamic D2 receptors in dementia with Lewy bodies, Parkinson's disease, and Parkinson's disease dementia.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2007;10(2):231-44.
2007: Myers Amanda J; Pittman Alan M; Zhao Alice S; Rohrer Kristen; Kaleem Mona; Marlowe Lauren; Lees Andrew; Leung Doris; McKeith Ian G; Perry Robert H; Morris Chris M; Trojanowski John Q; Clark Christopher; Karlawish Jason; Arnold Steve; Forman Mark S; Van Deerlin Vivianna; de Silva Rohan; Hardy John
The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts.
Neurobiology of disease 2007;25(3):561-70.
2007: Minger Stephen L; Ekonomou Antigoni; Carta Eloisa M; Chinoy Amish; Perry Robert H; Ballard Clive G
Endogenous neurogenesis in the human brain following cerebral infarction.
Regenerative medicine 2007;2(1):69-74.
2006: Ballard C; Ziabreva I; Perry R; Larsen J P; O'Brien J; McKeith I; Perry E; Aarsland D
Differences in neuropathologic characteristics across the Lewy body dementia spectrum.
Neurology 2006;67(11):1931-4.
2006: Mackenzie Ian R A; Baborie Atik; Pickering-Brown Stuart; Du Plessis Daniel; Jaros Evelyn; Perry Robert H; Neary David; Snowden Julie S; Mann David M A
Heterogeneity of ubiquitin pathology in frontotemporal lobar degeneration: classification and relation to clinical phenotype.
Acta neuropathologica 2006;112(5):539-49.
2006: Ziabreva Iryna; Perry Elaine; Perry Robert; Minger Stephen L; Ekonomou Antigoni; Przyborski Stefan; Ballard Clive
Altered neurogenesis in Alzheimer's disease.
Journal of psychosomatic research 2006;61(3):311-6.
2006: Polvikoski T; Kalaria R N; Perry R; Miller V; Kenny R A
Carotid sinus hypersensitivity associated with focal alpha-synucleinopathy of the autonomic nervous system.
Journal of neurology, neurosurgery, and psychiatry 2006;77(9):1064-6.
2006: Betts J; Jaros E; Perry R H; Schaefer A M; Taylor R W; Abdel-All Z; Lightowlers R N; Turnbull D M
Molecular neuropathology of MELAS: level of heteroplasmy in individual neurones and evidence of extensive vascular involvement.
Neuropathology and applied neurobiology 2006;32(4):359-73.
2006: Gotti Cecilia; Moretti Milena; Bohr Iwo; Ziabreva Iryna; Vailati Silvia; Longhi Renato; Riganti Loredana; Gaimarri Annalisa; McKeith Ian G; Perry Robert H; Aarsland Dag; Larsen Jan Petter; Sher Emanuele; Beattie Ruth; Clementi Francesco; Court Jennifer A
Selective nicotinic acetylcholine receptor subunit deficits identified in Alzheimer's disease, Parkinson's disease and dementia with Lewy bodies by immunoprecipitation.
Neurobiology of disease 2006;23(2):481-9.
2006: Bender Andreas; Krishnan Kim J; Morris Christopher M; Taylor Geoffrey A; Reeve Amy K; Perry Robert H; Jaros Evelyn; Hersheson Joshua S; Betts Joanne; Klopstock Thomas; Taylor Robert W; Turnbull Douglass M
High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease.
Nature genetics 2006;38(5):515-7.
2006: Momeni Parastoo; Cairns Nigel J; Perry Robert H; Bigio Eileen H; Gearing Marla; Singleton Andrew B; Hardy John
Mutation analysis of patients with neuronal intermediate filament inclusion disease (NIFID).
Neurobiology of aging 2006;27(5):778.e1-778.e6.
2006: Lewis H; Beher D; Cookson N; Oakley A; Piggott M; Morris C M; Jaros E; Perry R; Ince P; Kenny R A; Ballard C G; Shearman M S; Kalaria R N
Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia.
Neuropathology and applied neurobiology 2006;32(2):103-18.
2006: Ziabreva Iryna; Ballard Clive G; Aarsland Dag; Larsen Jan-Petter; McKeith Ian G; Perry Robert H; Perry Elaine K
Lewy body disease: thalamic cholinergic activity related to dementia and parkinsonism.
Neurobiology of aging 2006;27(3):433-8.
2006: Sahin Huseyin A; Emre Murat; Ziabreva Iryna; Perry Elaine; Celasun Bulent; Perry Robert
The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies.
Acta neuropathologica 2006;111(2):115-25.
2006: Pimlott Sally L; Piggott Margaret; Ballard Clive; McKeith Ian; Perry Robert; Kometa Simon; Owens Jonathan; Wyper David; Perry Elaine
Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies.
Neurobiology of disease 2006;21(1):50-6.
2005: McKeith I G; Dickson D W; Lowe J; Emre M; O'Brien J T; Feldman H; Cummings J; Duda J E; Lippa C; Perry E K; Aarsland D; Arai H; Ballard C G; Boeve B; Burn D J; Costa D; Del Ser T; Dubois B; Galasko D; Gauthier S; Goetz C G; Gomez-Tortosa E; Halliday G; Hansen L A; Hardy J; Iwatsubo T; Kalaria R N; Kaufer D; Kenny R A; Korczyn A; Kosaka K; Lee V M Y; Lees A; Litvan I; Londos E; Lopez O L; Minoshima S; Mizuno Y; Molina J A; Mukaetova-Ladinska E B; Pasquier F; Perry R H; Schulz J B; Trojanowski J Q; Yamada M;
Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.
Neurology 2005;65(12):1863-72.
2005: Aarsland Dag; Perry Robert; Brown Andrew; Larsen Jan P; Ballard Clive
Neuropathology of dementia in Parkinson's disease: a prospective, community-based study.
Annals of neurology 2005;58(5):773-6.
2005: Court J A; Johnson M; Religa D; Keverne J; Kalaria R; Jaros E; McKeith I G; Perry R; Naslund J; Perry E K
Attenuation of Abeta deposition in the entorhinal cortex of normal elderly individuals associated with tobacco smoking.
Neuropathology and applied neurobiology 2005;31(5):522-35.
2005: Ogungbo B I; Perry R H; Bozzino J; Mahadeva D
Report of GBM metastasis to the parotid gland.
Journal of neuro-oncology 2005;74(3):337-8.
2005: Ballard C G; Perry R H; McKeith I G; Perry E K
Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies.
International journal of geriatric psychiatry 2005;20(9):872-5.
2005: Ray M A; Graham A J; Lee M; Perry R H; Court J A; Perry E K
Neuronal nicotinic acetylcholine receptor subunits in autism: an immunohistochemical investigation in the thalamus.
Neurobiology of disease 2005;19(3):366-77.
2005: Nowotny Petra; Hinrichs Anthony L; Smemo Scott; Kauwe John S K; Maxwell Taylor; Holmans Peter; Hamshere Marian; Turic Dragana; Jehu Luke; Hollingworth Paul; Moore Pamela; Bryden Leslie; Myers Amanda; Doil Lisa M; Tacey Kristina M; Gibson Alison M; McKeith Ian G; Perry Robert H; Morris Chris M; Thal Leon; Morris John C; O'Donovan Michael C; Lovestone Simon; Grupe Andrew; Hardy John; Owen Michael J; Williams Julie; Goate Alison
Association studies between risk for late-onset Alzheimer's disease and variants in insulin degrading enzyme.
American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics 2005;136B(1):62-8.
2005: Teaktong Thanasak; Piggott Margaret A; Mckeith Ian G; Perry Robert H; Ballard Clive G; Perry Elaine K
Muscarinic M2 and M4 receptors in anterior cingulate cortex: relation to neuropsychiatric symptoms in dementia with Lewy bodies.
Behavioural brain research 2005;161(2):299-305.
2005: Aarsland Dag; Perry Robert; Larsen Jan P; McKeith Ian G; O'Brien John T; Perry Elaine K; Burn David; Ballard Clive G
Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias.
The Journal of clinical psychiatry 2005;66(5):633-7.
2005: Pyle Angela; Foltynie Thomas; Tiangyou Watcharee; Lambert Claire; Keers Sharon M; Allcock Liesl M; Davison Jill; Lewis Simon J; Perry Robert H; Barker Roger; Burn David J; Chinnery Patrick F
Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD.
Annals of neurology 2005;57(4):564-7.
2005: Bohr I J; Ray M A; McIntosh J M; Chalon S; Guilloteau D; McKeith I G; Perry R H; Clementi F; Perry E K; Court J A; Piggott M A
Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.
Experimental neurology 2005;191(2):292-300.
2005: Perry E; Ziabreva I; Perry R; Aarsland D; Ballard C
Absence of cholinergic deficits in "pure" vascular dementia.
Neurology 2005;64(1):132-3.
2005: Ballard Clive; Morris Christopher; Kalaria Rajesh; McKeith Ian; Perry Robert; Perry Elaine
The k variant of the butyrylcholinesterase gene is associated with reduced phosphorylation of tau in dementia patients.
Dementia and geriatric cognitive disorders 2005;19(5-6):357-60.
2004: Aarsland Dag; Andersen Kjeld; Larsen Jan Petter; Perry Robert; Wentzel-Larsen Tore; Lolk Anette; Kragh-Sørensen Per
The rate of cognitive decline in Parkinson disease.
Archives of neurology 2004;61(12):1906-11.
2004: Ray Melissa; Bohr Iwo; McIntosh J Michael; Ballard Clive; McKeith Ian; Chalon Sylvie; Guilloteau Denis; Perry Robert; Perry Elaine; Court J A; Piggott Margaret
Involvement of alpha6/alpha3 neuronal nicotinic acetylcholine receptors in neuropsychiatric features of Dementia with Lewy bodies: [(125)I]-alpha-conotoxin MII binding in the thalamus and striatum.
Neuroscience letters 2004;372(3):220-5.
2004: Mukaetova-Ladinska E B; Arnold H; Jaros E; Perry R; Perry E
Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals.
Neuropathology and applied neurobiology 2004;30(6):615-23.
2004: Busby J; O'Brien K K; Gibson A M; McKeith I G; Perry R H; Hardy J A; Singleton A B; Morris C M
Dementia with Lewy bodies: no association of polymorphisms in the human synphilin gene.
Neurogenetics 2004;5(4):251-2.
2004: Kalaria Raj N; Kenny Rose Anne; Ballard Clive G; Perry Robert; Ince Paul; Polvikoski Tuomo
Towards defining the neuropathological substrates of vascular dementia.
Journal of the neurological sciences 2004;226(1-2):75-80.
2004: Cairns N J; Grossman M; Arnold S E; Burn D J; Jaros E; Perry R H; Duyckaerts C; Stankoff B; Pillon B; Skullerud K; Cruz-Sanchez F F; Bigio E H; Mackenzie I R A; Gearing M; Juncos J L; Glass J D; Yokoo H; Nakazato Y; Mosaheb S; Thorpe J R; Uryu K; Lee V M-Y; Trojanowski J Q
Clinical and neuropathologic variation in neuronal intermediate filament inclusion disease.
Neurology 2004;63(8):1376-84.
2004: Teaktong Thanasak; Graham Alison J; Court Jennifer A; Perry Robert H; Jaros Evelyn; Johnson Mary; Hall Ros; Perry Elaine K
Nicotinic acetylcholine receptor immunohistochemistry in Alzheimer's disease and dementia with Lewy bodies: differential neuronal and astroglial pathology.
Journal of the neurological sciences 2004;225(1-2):39-49.
2004: Cairns Nigel J; Uryu Kunihiro; Bigio Eileen H; Mackenzie Ian R A; Gearing Marla; Duyckaerts Charles; Yokoo Hideaki; Nakazato Yoichi; Jaros Evelyn; Perry Robert H; Arnold Steven E; Lee Virginia M-Y; Trojanowski John Q
alpha-Internexin aggregates are abundant in neuronal intermediate filament inclusion disease (NIFID) but rare in other neurodegenerative diseases.
Acta neuropathologica 2004;108(3):213-23.
2004: Fernando M S; O'Brien J T; Perry R H; English P; Forster G; McMeekin W; Slade J Y; Golkhar A; Matthews F E; Barber R; Kalaria R N; Ince P G;
Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain.
Neuropathology and applied neurobiology 2004;30(4):385-95.
2004: Johnson J; Hague S M; Hanson M; Gibson A; Wilson K E; Evans E W; Singleton A A; McInerney-Leo A; Nussbaum R L; Hernandez D G; Gallardo M; McKeith I G; Burn D J; Ryu M; Hellstrom O; Ravina B; Eerola J; Perry R H; Jaros E; Tienari P; Weiser R; Gwinn-Hardy K; Morris C M; Hardy J; Singleton A B
SNCA multiplication is not a common cause of Parkinson disease or dementia with Lewy bodies.
Neurology 2004;63(3):554-6.
2004: Cairns Nigel J; Zhukareva Victoria; Uryu Kunihiro; Zhang Bin; Bigio Eileen; Mackenzie Ian R A; Gearing Marla; Duyckaerts Charles; Yokoo Hideaki; Nakazato Yoichi; Jaros Evelyn; Perry Robert H; Lee Virginia M-Y; Trojanowski John Q
alpha-internexin is present in the pathological inclusions of neuronal intermediate filament inclusion disease.
The American journal of pathology 2004;164(6):2153-61.
2004: Walker Z; Costa D C; Walker R W H; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona C L E
Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
Neurology 2004;62(9):1568-72.
2004: Ballard Clive G; Jacoby Robin; Del Ser Teodoro; Khan M Nadeem; Munoz David G; Holmes Clive; Nagy Zsuzanna; Perry Elaine K; Joachim Catherine; Jaros Evelyn; O'Brien John T; Perry Robert H; McKeith Ian G
Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with lewy bodies.
The American journal of psychiatry 2004;161(5):843-9.
2004: Martin-Ruiz C M; Lee M; Perry R H; Baumann M; Court J A; Perry E K
Molecular analysis of nicotinic receptor expression in autism.
Brain research. Molecular brain research 2004;123(1-2):81-90.
2004: Cairns N J; Jaros E; Perry R H; Armstrong R A
Temporal lobe pathology of human patients with neurofilament inclusion disease.
Neuroscience letters 2004;354(3):245-7.
2004: Pimlott S L; Piggott M; Owens J; Greally E; Court J A; Jaros E; Perry R H; Perry E K; Wyper D
Nicotinic acetylcholine receptor distribution in Alzheimer's disease, dementia with Lewy bodies, Parkinson's disease, and vascular dementia: in vitro binding study using 5-[(125)i]-a-85380.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2004;29(1):108-16.
2004: Perry Elaine K; Perry Robert H
Neurochemistry of consciousness: cholinergic pathologies in the human brain.
Progress in brain research 2004;145():287-99.
2003: Thomas Alan J; O'Brien John T; Barber Robert; McMeekin William; Perry Robert
A neuropathological study of periventricular white matter hyperintensities in major depression.
Journal of affective disorders 2003;76(1-3):49-54.
2003: Perry Elaine K; Kilford Linda; Lees Andrew J; Burn David J; Perry Robert H
Increased Alzheimer pathology in Parkinson's disease related to antimuscarinic drugs.
Annals of neurology 2003;54(2):235-8.
2003: O'Brien John T; Thomas Alan; English Philip; Perry Robert; Jaros Evelyn
A prospectively studied clinicopathological case of 'vascular depression'.
International journal of geriatric psychiatry 2003;18(7):656-7.
2003: Cairns Nigel J; Perry Robert H; Jaros Evelyn; Burn David; McKeith Ian G; Lowe James S; Holton Janice; Rossor Martin N; Skullerud Kari; Duyckaerts Charles; Cruz-Sanchez Felix F; Lantos Peter L
Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions.
Neuroscience letters 2003;341(3):177-80.
2003: Stone J; Griffiths T D; Rastogi S; Perry R H; Cleland P G
Non-Picks frontotemporal dementia imitating schizophrenia in a 22-year-old man.
Journal of neurology 2003;250(3):369-70.
2003: Piggott Margaret A; Owens Jonathan; O'Brien John; Colloby Sean; Fenwick John; Wyper David; Jaros Evelyn; Johnson Mary; Perry Robert H; Perry Elaine K
Muscarinic receptors in basal ganglia in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease.
Journal of chemical neuroanatomy 2003;25(3):161-73.
2003: Graham A J; Ray M A; Perry E K; Jaros E; Perry R H; Volsen S G; Bose S; Evans N; Lindstrom J; Court J A
Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus.
Journal of chemical neuroanatomy 2003;25(2):97-113.
2003: McKeith Ian G; Burn David J; Ballard Clive G; Collerton Daniel; Jaros Evelyn; Morris Chris M; McLaren Andrew; Perry Elaine K; Perry Robert; Piggott Margaret A; O'Brien John T
Dementia with Lewy bodies.
Seminars in clinical neuropsychiatry 2003;8(1):46-57.
2003: Teaktong Thanasak; Graham Alison; Court Jennifer; Perry Robert; Jaros Evelyn; Johnson Mary; Hall Ros; Perry Elaine
Alzheimer's disease is associated with a selective increase in alpha7 nicotinic acetylcholine receptor immunoreactivity in astrocytes.
Glia 2003;41(2):207-11.
2003: Thomas Alan J; Perry Robert; Kalaria Rajesh N; Oakley Arthur; McMeekin William; O'Brien John T
Neuropathological evidence for ischemia in the white matter of the dorsolateral prefrontal cortex in late-life depression.
International journal of geriatric psychiatry 2003;18(1):7-13.
2002: Martin-Ruiz C; Lawrence S; Piggott M; Kuryatov A; Lindstrom J; Gotti C; Cookson M R; Perry R H; Jaros E; Perry E K; Court J A
Nicotinic receptors in the putamen of patients with dementia with Lewy bodies and Parkinson's disease: relation to changes in alpha-synuclein expression.
Neuroscience letters 2002;335(2):134-8.
2002: Thomas Alan J; Perry Robert; Barber Robert; Kalaria Raj N; O'Brien John T
Pathologies and pathological mechanisms for white matter hyperintensities in depression.
Annals of the New York Academy of Sciences 2002;977():333-9.
2002: Davis S; Thomas A; Perry R; Oakley A; Kalaria R N; O'Brien J T
Glial fibrillary acidic protein in late life major depressive disorder: an immunocytochemical study.
Journal of neurology, neurosurgery, and psychiatry 2002;73(5):556-60.
2002: Ballard Clive G; Court Jennifer A; Piggott Margaret; Johnson Mary; O'Brien John; McKeith Ian; Holmes Clive; Lantos Peter; Jaros Evelyn; Perry Robert; Perry E
Disturbances of consciousness in dementia with Lewy bodies associated with alteration in nicotinic receptor binding in the temporal cortex.
Consciousness and cognition 2002;11(3):461-74.
2002: Piggott Margaret; Owens Jonathan; O'Brien John; Paling Sean; Wyper David; Fenwick John; Johnson Mary; Perry Robert; Perry Elaine
Comparative distribution of binding of the muscarinic receptor ligands pirenzepine, AF-DX 384, (R,R)-I-QNB and (R,S)-I-QNB to human brain.
Journal of chemical neuroanatomy 2002;24(3):211-23.
2002: Thomas Alan J; O'Brien John T; Davis Sue; Ballard Clive; Barber Robert; Kalaria Rajesh N; Perry Robert H
Ischemic basis for deep white matter hyperintensities in major depression: a neuropathological study.
Archives of general psychiatry 2002;59(9):785-92.
2002: Lee M; Martin-Ruiz C; Graham A; Court J; Jaros E; Perry R; Iversen P; Bauman M; Perry E
Nicotinic receptor abnormalities in the cerebellar cortex in autism.
Brain : a journal of neurology 2002;125(Pt 7):1483-95.
2002: SantaCruz K S; Walker Z; Swagerty D; Piggott M A; Ryo-Yang M; McKeith I G; Raghavan R; Jaros E; Perry R H
Clinical presentations in monozygotic twins with dementia with Lewy bodies.
Journal of the American Medical Directors Association 2002;3(3):175-9.
2002: Ballard Clive; Johnson Mary; Piggott Margaret; Perry Robert; O'Brien John; Rowan Elise; Perry Elaine; Lantos Peter; Cairns Nigel; Holmes Clive
A positive association between 5HT re-uptake binding sites and depression in dementia with Lewy bodies.
Journal of affective disorders 2002;69(1-3):219-23.
2002: Burns A S Y W; Jaros E; Cole M; Perry R; Pearson A J; Lunec J
The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system.
British journal of cancer 2002;86(7):1117-23.
2002: Carter M; Nicholson J; Ross F; Crolla J; Allibone R; Balaji V; Perry R; Walker D; Gilbertson R; Ellison D W
Genetic abnormalities detected in ependymomas by comparative genomic hybridisation.
British journal of cancer 2002;86(6):929-39.
2002: Singleton Andrew B; Wharton Anna; O'Brien Kirsty K; Walker Matthew P; McKeith Ian G; Ballard Clive G; O'Brien John; Perry Robert H; Ince Paul G; Edwardson James A; Morris Christopher M
Clinical and neuropathological correlates of apolipoprotein E genotype in dementia with Lewy bodies.
Dementia and geriatric cognitive disorders 2002;14(4):167-75.
2002: Graham A; Court J A; Martin-Ruiz C M; Jaros E; Perry R; Volsen S G; Bose S; Evans N; Ince P; Kuryatov A; Lindstrom J; Gotti C; Perry E K
Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum.
Neuroscience 2002;113(3):493-507.
2001: Court J A; Ballard C G; Piggott M A; Johnson M; O'Brien J T; Holmes C; Cairns N; Lantos P; Perry R H; Jaros E; Perry E K
Visual hallucinations are associated with lower alpha bungarotoxin binding in dementia with Lewy bodies.
Pharmacology, biochemistry, and behavior 2001;70(4):571-9.
2001: Gilbertson R; Wickramasinghe C; Hernan R; Balaji V; Hunt D; Jones-Wallace D; Crolla J; Perry R; Lunec J; Pearson A; Ellison D
Clinical and molecular stratification of disease risk in medulloblastoma.
British journal of cancer 2001;85(5):705-12.
2001: Marutle A; Zhang X; Court J; Piggott M; Johnson M; Perry R; Perry E; Nordberg A
Laminar distribution of nicotinic receptor subtypes in cortical regions in schizophrenia.
Journal of chemical neuroanatomy 2001;22(1-2):115-26.
2001: Perry E K; Lee M L; Martin-Ruiz C M; Court J A; Volsen S G; Merrit J; Folly E; Iversen P E; Bauman M L; Perry R H; Wenk G L
Cholinergic activity in autism: abnormalities in the cerebral cortex and basal forebrain.
The American journal of psychiatry 2001;158(7):1058-66.
2001: Gilbertson R; Hernan R; Pietsch T; Pinto L; Scotting P; Allibone R; Ellison D; Perry R; Pearson A; Lunec J
Novel ERBB4 juxtamembrane splice variants are frequently expressed in childhood medulloblastoma.
Genes, chromosomes & cancer 2001;31(3):288-94.
2001: Lloyd A J; Grace J B; Jaros E; Perry R H; Fairbairn A F; Swann A G; O'Brien J T; McKeith I G
Depression in late life, cognitive decline and white matter pathology in two clinico-pathologically investigated cases.
International journal of geriatric psychiatry 2001;16(3):281-7.
2001: O'Brien J; Thomas A; Ballard C; Brown A; Ferrier N; Jaros E; Perry R
Cognitive impairment in depression is not associated with neuropathologic evidence of increased vascular or Alzheimer-type pathology.
Biological psychiatry 2001;49(2):130-6.
2001: Thomas A J; Ferrier I N; Kalaria R N; Perry R H; Brown A; O'Brien J T
A neuropathological study of vascular factors in late-life depression.
Journal of neurology, neurosurgery, and psychiatry 2001;70(1):83-7.
2001: Aarsland D; Ballard C; McKeith I; Perry R H; Larsen J P
Comparison of extrapyramidal signs in dementia with Lewy bodies and Parkinson's disease.
The Journal of neuropsychiatry and clinical neurosciences 2001;13(3):374-9.
2001: Kalaria R N; Ballard C G; Ince P G; Kenny R A; McKeith I G; Morris C M; O'Brien J T; Perry E K; Perry R H; Edwardson J A
Multiple substrates of late-onset dementia: implications for brain protection.
Novartis Foundation symposium 2001;235():49-60; discussion 60-5.
2000: Ballard C; Piggott M; Johnson M; Cairns N; Perry R; McKeith I; Jaros E; O'Brien J; Holmes C; Perry E
Delusions associated with elevated muscarinic binding in dementia with Lewy bodies.
Annals of neurology 2000;48(6):868-76.
2000: Singleton A B; Hall R; Ballard C G; Perry R H; Xuereb J H; Rubinsztein D C; Tysoe C; Matthews P; Cordell B; Kumar-Singh S; De Jonghe C; Cruts M; van Broeckhoven C; Morris C M
Pathology of early-onset Alzheimer's disease cases bearing the Thr113-114ins presenilin-1 mutation.
Brain : a journal of neurology 2000;123 Pt 12():2467-74.
2000: Martin-Ruiz C M; Piggott M; Gotti C; Lindstrom J; Mendelow A D; Siddique M S; Perry R H; Perry E K; Court J A
Alpha and beta nicotinic acetylcholine receptors subunits and synaptophysin in putamen from Parkinson's disease.
Neuropharmacology 2000;39(13):2830-9.
2000: Thomas A J; Ferrier I N; Kalaria R N; Woodward S A; Ballard C; Oakley A; Perry R H; O'Brien J T
Elevation in late-life depression of intercellular adhesion molecule-1 expression in the dorsolateral prefrontal cortex.
The American journal of psychiatry 2000;157(10):1682-4.
2000: Ballard C; Neill D; O'Brien J; McKeith I G; Ince P; Perry R
Anxiety, depression and psychosis in vascular dementia: prevalence and associations.
Journal of affective disorders 2000;59(2):97-106.
2000: Chinnery P F; Taylor G A; Howell N; Andrews R M; Morris C M; Taylor R W; McKeith I G; Perry R H; Edwardson J A; Turnbull D M
Mitochondrial DNA haplogroups and susceptibility to AD and dementia with Lewy bodies.
Neurology 2000;55(2):302-4.
2000: Ballard C; O'Brien J; Swann A; Neill D; Lantos P; Holmes C; Burn D; Ince P; Perry R; McKeith I
One year follow-up of parkinsonism in dementia with Lewy bodies.
Dementia and geriatric cognitive disorders 2000;11(4):219-22.
2000: O'Brien J; Perry R; Barber R; Gholkar A; Thomas A
The association between white matter lesions on magnetic resonance imaging and noncognitive symptoms.
Annals of the New York Academy of Sciences 2000;903():482-9.
2000: Perry E; Martin-Ruiz C; Lee M; Griffiths M; Johnson M; Piggott M; Haroutunian V; Buxbaum J D; Nãsland J; Davis K; Gotti C; Clementi F; Tzartos S; Cohen O; Soreq H; Jaros E; Perry R; Ballard C; McKeith I; Court J
Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases.
European journal of pharmacology 2000;393(1-3):215-22.
2000: McKeith I G; Ballard C G; Perry R H; Ince P G; O'Brien J T; Neill D; Lowery K; Jaros E; Barber R; Thompson P; Swann A; Fairbairn A F; Perry E K
Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.
Neurology 2000;54(5):1050-8.
2000: Ballard C; McKeith I; O'Brien J; Kalaria R; Jaros E; Ince P; Perry R
Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes.
Dementia and geriatric cognitive disorders 2000;11(2):59-65.
2000: Xu W; Liu L; Emson P; Harrington C R; McKeith I G; Perry R H; Morris C M; Charles I G
The CCTTT polymorphism in the NOS2A gene is associated with dementia with Lewy bodies.
Neuroreport 2000;11(2):297-9.
2000: Gibson A M; Singleton A B; Smith G; Woodward R; McKeith I G; Perry R H; Ince P G; Ballard C G; Edwardson J A; Morris C M
Lack of association of the alpha2-macroglobulin locus on chromosome 12 in AD.
Neurology 2000;54(2):433-8.
2000: Martin-Ruiz C; Court J; Lee M; Piggott M; Johnson M; Ballard C; Kalaria R; Perry R; Perry E
Nicotinic receptors in dementia of Alzheimer, Lewy body and vascular types.
Acta neurologica Scandinavica. Supplementum 2000;176():34-41.
2000: Court J A; Piggott M A; Lloyd S; Cookson N; Ballard C G; McKeith I G; Perry R H; Perry E K
Nicotine binding in human striatum: elevation in schizophrenia and reductions in dementia with Lewy bodies, Parkinson's disease and Alzheimer's disease and in relation to neuroleptic medication.
Neuroscience 2000;98(1):79-87.
1999: Neill D; Curran M D; Middleton D; Mawhinney H; Edwardson J A; McKeith I; Ballard C; Morris C; Ince P; Jaros E; Perry R
Risk for Alzheimer's disease in older late-onset cases is associated with HLA-DRB1*03.
Neuroscience letters 1999;275(2):137-40.
1999: Martin-Ruiz C M; Court J A; Molnar E; Lee M; Gotti C; Mamalaki A; Tsouloufis T; Tzartos S; Ballard C; Perry R H; Perry E K
Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease.
Journal of neurochemistry 1999;73(4):1635-40.
1999: Court J; Spurden D; Lloyd S; McKeith I; Ballard C; Cairns N; Kerwin R; Perry R; Perry E
Neuronal nicotinic receptors in dementia with Lewy bodies and schizophrenia: alpha-bungarotoxin and nicotine binding in the thalamus.
Journal of neurochemistry 1999;73(4):1590-7.
1999: McKeith I G; Perry E K; Perry R H
Report of the second dementia with Lewy body international workshop: diagnosis and treatment. Consortium on Dementia with Lewy Bodies.
Neurology 1999;53(5):902-5.
1999: Piggott M A; Marshall E F; Thomas N; Lloyd S; Court J A; Jaros E; Burn D; Johnson M; Perry R H; McKeith I G; Ballard C; Perry E K
Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution.
Brain : a journal of neurology 1999;122 ( Pt 8)():1449-68.
1999: Ballard C; Holmes C; McKeith I; Neill D; O'Brien J; Cairns N; Lantos P; Perry E; Ince P; Perry R
Psychiatric morbidity in dementia with Lewy bodies: a prospective clinical and neuropathological comparative study with Alzheimer's disease.
The American journal of psychiatry 1999;156(7):1039-45.
1999: Barber R; Scheltens P; Gholkar A; Ballard C; McKeith I; Ince P; Perry R; O'Brien J
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging.
Journal of neurology, neurosurgery, and psychiatry 1999;67(1):66-72.
1999: Perry E; Walker M; Grace J; Perry R
Acetylcholine in mind: a neurotransmitter correlate of consciousness?
Trends in neurosciences 1999;22(6):273-80.
1999: Singleton A B; Gibson A M; McKeith I G; Ballard C A; Perry R H; Ince P G; Edwardson J A; Morris C M
Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies.
Neuroreport 1999;10(7):1507-10.
1999: Piggott M A; Marshall E F; Thomas N; Lloyd S; Court J A; Jaros E; Costa D; Perry R H; Perry E K
Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
Neuroscience 1999;90(2):433-45.
1999: Middleton D; Mawhinney H; Curran M D; Edwardson J A; Perry R; McKeith I; Morris C; Ince P G; Neill D
Frequency of HLA-A and B alleles in early and late-onset Alzheimer's disease.
Neuroscience letters 1999;262(2):140-2.
1999: Briel R C; McKeith I G; Barker W A; Hewitt Y; Perry R H; Ince P G; Fairbairn A F
EEG findings in dementia with Lewy bodies and Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1999;66(3):401-3.
1999: Ballard C G; Ayre G; O'Brien J; Sahgal A; McKeith I G; Ince P G; Perry R H
Simple standardised neuropsychological assessments aid in the differential diagnosis of dementia with Lewy bodies from Alzheimer's disease and vascular dementia.
Dementia and geriatric cognitive disorders 1999;10(2):104-8.
1999: Atkinson A; Singleton A B; Steward A; Ince P G; Perry R H; McKeith I G; Fairbairn A F; Edwardson J A; Daly A K; Morris C M
CYP2D6 is associated with Parkinson's disease but not with dementia with Lewy Bodies or Alzheimer's disease.
Pharmacogenetics 1999;9(1):31-5.
1999: Goodchild R E; Court J A; Hobson I; Piggott M A; Perry R H; Ince P; Jaros E; Perry E K
Distribution of histamine H3-receptor binding in the normal human basal ganglia: comparison with Huntington's and Parkinson's disease cases.
The European journal of neuroscience 1999;11(2):449-56.
1999: Harvey G T; Hughes J; McKeith I G; Briel R; Ballard C; Gholkar A; Scheltens P; Perry R H; Ince P; O'Brien J T
Magnetic resonance imaging differences between dementia with Lewy bodies and Alzheimer's disease: a pilot study.
Psychological medicine 1999;29(1):181-7.
1998: El-Agnaf O M; Curran M D; Wallace A; Middleton D; Murgatroyd C; Curtis A; Perry R; Jaros E
Mutation screening in exons 3 and 4 of alpha-synuclein in sporadic Parkinson's and sporadic and familial dementia with Lewy bodies cases.
Neuroreport 1998;9(17):3925-7.
1998: Terzano S; Court J A; Fornasari D; Griffiths M; Spurden D P; Lloyd S; Perry R H; Perry E K; Clementi F
Expression of the alpha3 nicotinic receptor subunit mRNA in aging and Alzheimer's disease.
Brain research. Molecular brain research 1998;63(1):72-8.
1998: Court J A; Lloyd S; Thomas N; Piggott M A; Marshall E F; Morris C M; Lamb H; Perry R H; Johnson M; Perry E K
Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use.
Neuroscience 1998;87(1):63-78.
1998: Piggott M A; Perry E K; Marshall E F; McKeith I G; Johnson M; Melrose H L; Court J A; Lloyd S; Fairbairn A; Brown A; Thompson P; Perry R H
Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.
Biological psychiatry 1998;44(8):765-74.
1998: Ballard C G; O'Brien J; Lowery K; Ayre G A; Harrison R; Perry R; Ince P; Neill D; McKeith I G
A prospective study of dementia with Lewy bodies.
Age and ageing 1998;27(5):631-6.
1998: Gilbertson R J; Clifford S C; MacMeekin W; Meekin W; Wright C; Perry R H; Kelly P; Pearson A D; Lunec J
Expression of the ErbB-neuregulin signaling network during human cerebellar development: implications for the biology of medulloblastoma.
Cancer research 1998;58(17):3932-41.
1998: Lyras L; Perry R H; Perry E K; Ince P G; Jenner A; Jenner P; Halliwell B
Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies.
Journal of neurochemistry 1998;71(1):302-12.
1998: Singleton A B; Smith G; Gibson A M; Woodward R; Perry R H; Ince P G; Edwardson J A; Morris C M
No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease.
Human molecular genetics 1998;7(5):937-9.
1998: Lamb H; Christie J; Singleton A B; Leake A; Perry R H; Ince P G; McKeith I G; Melton L M; Edwardson J A; Morris C M
Apolipoprotein E and alpha-1 antichymotrypsin polymorphism genotyping in Alzheimer's disease and in dementia with Lewy bodies. Distinctions between diseases.
Neurology 1998;50(2):388-91.
1998: Perry E; Court J; Goodchild R; Griffiths M; Jaros E; Johnson M; Lloyd S; Piggott M; Spurden D; Ballard C; McKeith I; Perry R
Clinical neurochemistry: developments in dementia research based on brain bank material.
Journal of neural transmission (Vienna, Austria : 1996) 1998;105(8-9):915-33.
1998: McKeith I G; Ince P; Jaros E B; Fairbairn A; Ballard C; Grace J; Morris C M; Perry R H
What are the relations between Lewy body disease and AD?
Journal of neural transmission. Supplementum 1998;54():107-16.
1997: Ballard C; McKeith I; Harrison R; O'Brien J; Thompson P; Lowery K; Perry R; Ince P
A detailed phenomenological comparison of complex visual hallucinations in dementia with Lewy bodies and Alzheimer's disease.
International psychogeriatrics / IPA 1997;9(4):381-8.
1997: Ballard C; McKeith I; Burn D; Harrison R; O'Brien J; Lowery K; Campbell M; Perry R; Ince P
The UPDRS scale as a means of identifying extrapyramidal signs in patients suffering from dementia with Lewy bodies.
Acta neurologica Scandinavica 1997;96(6):366-71.
1997: Thompson J; Thomas N; Singleton A; Piggott M; Lloyd S; Perry E K; Morris C M; Perry R H; Ferrier I N; Court J A
D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele.
Pharmacogenetics 1997;7(6):479-84.
1997: Singleton A B; Lamb H; Leake A; McKeith I G; Ince P G; Perry R H; Morris C M
No association between a polymorphism in the presenilin 1 gene and dementia with Lewy bodies.
Neuroreport 1997;8(16):3637-9.
1997: Singleton A B; Lamb H; Leake A; McKeith I G; Perry R H; Morris C M
No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer's disease.
Neuroscience letters 1997;234(1):19-22.
1997: Gilbertson R J; Perry R H; Kelly P J; Pearson A D; Lunec J
Prognostic significance of HER2 and HER4 coexpression in childhood medulloblastoma.
Cancer research 1997;57(15):3272-80.
1997: Spurden D P; Court J A; Lloyd S; Oakley A; Perry R; Pearson C; Pullen R G; Perry E K
Nicotinic receptor distribution in the human thalamus: autoradiographical localization of [3H]nicotine and [125I] alpha-bungarotoxin binding.
Journal of chemical neuroanatomy 1997;13(2):105-13.
1997: Court J A; Lloyd S; Johnson M; Griffiths M; Birdsall N J; Piggott M A; Oakley A E; Ince P G; Perry E K; Perry R H
Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging.
Brain research. Developmental brain research 1997;101(1-2):93-105.
1997: Marshall E F; Perry R H; Perry E K; Piggott M A; Thompson P; Jaros E; Burn D J
Striatal dopaminergic loss without parkinsonism in a case of corticobasal degeneration.
Acta neurologica Scandinavica 1997;95(5):287-92.
1997: Gilbertson R J; Jaros E; Perry R H; Kelly P J; Lunec J; Pearson A D
Mitotic percentage index: a new prognostic factor for childhood medulloblastoma.
European journal of cancer (Oxford, England : 1990) 1997;33(4):609-15.
1997: Curran M; Middleton D; Edwardson J; Perry R; McKeith I; Morris C; Neill D
HLA-DR antigens associated with major genetic risk for late-onset Alzheimer's disease.
Neuroreport 1997;8(6):1467-9.
1997: Mann D M; Iwatsubo T; Pickering-Brown S M; Owen F; Saido T C; Perry R H
Preferential deposition of amyloid beta protein (Abeta) in the form Abeta40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele.
Neuroscience letters 1997;221(2-3):81-4.
1997: Perry R; McKeith I; Perry E
Lewy body dementia--clinical, pathological and neurochemical interconnections.
Journal of neural transmission. Supplementum 1997;51():95-109.
1997: Davis M; Perry R H; Mendelow A D
The effect of non-competitive N-methyl-D-aspartate receptor antagonism on cerebral oedema and cerebral infarct size in the aging ischaemic brain.
Acta neurochirurgica. Supplement 1997;70():30-3.
1996: McKeith I G; Galasko D; Kosaka K; Perry E K; Dickson D W; Hansen L A; Salmon D P; Lowe J; Mirra S S; Byrne E J; Lennox G; Quinn N P; Edwardson J A; Ince P G; Bergeron C; Burns A; Miller B L; Lovestone S; Collerton D; Jansen E N; Ballard C; de Vos R A; Wilcock G K; Jellinger K A; Perry R H
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop.
Neurology 1996;47(5):1113-24.
1996: Bailey S; Skinner R; Lucraft H H; Perry R H; Todd N; Pearson A D
Pineal tumours in the north of England 1968-93.
Archives of disease in childhood 1996;75(3):181-5.
1996: Morris A A; Singh-Kler R; Perry R H; Griffiths P D; Burt A D; Wong C P; Gardner-Medwin D; Turnbull D M
Respiratory chain dysfunction in progressive neuronal degeneration of childhood with liver disease.
Journal of child neurology 1996;11(5):417-9.
1996: Johnson M; Perry R H; Piggott M A; Court J A; Spurden D; Lloyd S; Ince P G; Perry E K
Glutamate receptor binding in the human hippocampus and adjacent cortex during development and aging.
Neurobiology of aging 1996;17(4):639-51.
1996: Perry E K; Court J A; Lloyd S; Johnson M; Griffiths M H; Spurden D; Piggott M A; Turner J; Perry R H
Beta-amyloidosis in normal aging and transmitter signaling in human temporal lobe.
Annals of the New York Academy of Sciences 1996;777():388-92.
1996: Royston M C; Mann D; Pickering-Brown S; Owen F; Perry R; Ragbavan R; Khin-Nu C; Tyner S; Day K; Crook R; Hardy J; Roberts G W
ApoE2 allele, Down's syndrome, and dementia.
Annals of the New York Academy of Sciences 1996;777():255-9.
1996: Morris C M; Massey H M; Benjamin R; Leake A; Broadbent C; Griffiths M; Lamb H; Brown A; Ince P G; Tyrer S; Thompson P; McKeith I G; Edwardson J A; Perry R H; Perry E K
Molecular biology of APO E alleles in Alzheimer's and non-Alzheimer's dementias.
Journal of neural transmission. Supplementum 1996;47():205-18.
1996: McKenzie J E; Edwards R J; Gentleman S M; Ince P G; Perry R H; Royston M C; Roberts G W
A quantitative comparison of plaque types in Alzheimer's disease and senile dementia of the Lewy body type.
Acta neuropathologica 1996;91(5):526-9.
1995: Benjamin R; Leake A; Ince P G; Perry R H; McKeith I G; Edwardson J A; Morris C M
Effects of apolipoprotein E genotype on cortical neuropathology in senile dementia of the Lewy body and Alzheimer's disease.
Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration 1995;4(4):443-8.
1995: Raghavan R; Day K A; Perry R H
Rapid cycling bipolar affective disorder and familial learning disability associated with temporal lobe (occipitotemporal gyrus) cortical dysplasia.
Journal of intellectual disability research : JIDR 1995;39 ( Pt 6)():509-19.
1995: Perry E K; Perry R H
Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness.
Brain and cognition 1995;28(3):240-58.
1995: Mantle D; Falkous G; Ishiura S; Perry R H; Perry E K
Comparison of cathepsin protease activities in brain tissue from normal cases and cases with Alzheimer's disease, Lewy body dementia, Parkinson's disease and Huntington's disease.
Journal of the neurological sciences 1995;131(1):65-70.
1995: Davis M; Mendelow A D; Perry R H; Chambers I R; James O F
Experimental stroke and neuroprotection in the aging rat brain.
Stroke; a journal of cerebral circulation 1995;26(6):1072-8.
1995: Gilbertson R J; Pearson A D; Perry R H; Jaros E; Kelly P J
Prognostic significance of the c-erbB-2 oncogene product in childhood medulloblastoma.
British journal of cancer 1995;71(3):473-7.
1995: Perry E K; Morris C M; Court J A; Cheng A; Fairbairn A F; McKeith I G; Irving D; Brown A; Perry R H
Alteration in nicotine binding sites in Parkinson's disease, Lewy body dementia and Alzheimer's disease: possible index of early neuropathology.
Neuroscience 1995;64(2):385-95.
1995: Strong C; Anderton B H; Perry R H; Perry E K; Ince P G; Lovestone S
Abnormally phosphorylated tau protein in senile dementia of Lewy body type and Alzheimer disease: evidence that the disorders are distinct.
Alzheimer disease and associated disorders 1995;9(4):218-22.
1994: Harrington C R; Louwagie J; Rossau R; Vanmechelen E; Perry R H; Perry E K; Xuereb J H; Roth M; Wischik C M
Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.
The American journal of pathology 1994;145(6):1472-84.
1994: Royston M C; Mann D; Pickering-Brown S; Owen F; Perry R; Raghavan R; Khin-Nu C; Tyrer S; Day K; Crook R
Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia.
Neuroreport 1994;5(18):2583-5.
1994: Hardy J; Crook R; Prihar G; Roberts G; Raghavan R; Perry R
Senile dementia of the Lewy body type has an apolipoprotein E epsilon 4 allele frequency intermediate between controls and Alzheimer's disease.
Neuroscience letters 1994;182(1):1-2.
1994: McKeith I G; Fairbairn A F; Perry R H; Thompson P
The clinical diagnosis and misdiagnosis of senile dementia of Lewy body type (SDLT).
The British journal of psychiatry : the journal of mental science 1994;165(3):324-32.
1994: Harrington C R; Perry R H; Perry E K; Hurt J; McKeith I G; Roth M; Wischik C M
Senile dementia of Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau protein.
Dementia (Basel, Switzerland) 1994;5(5):215-28.
1994: Rempfer R; Crook R; Houlden H; Duff K; Hutton M; Roberts G W; Raghavan R; Perry R; Hardy J
Parkinson's disease, but not Alzheimer's disease, Lewy body variant associated with mutant alleles at cytochrome P450 gene.
Lancet 1994;344(8925):815.
1994: St Clair D; Norrman J; Perry R; Yates C; Wilcock G; Brookes A
Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls.
Neuroscience letters 1994;176(1):45-6.
1994: Raghavan R; Khin-Nu C; Brown A G; Day K A; Tyrer S P; Ince P G; Perry E K; Perry R H
Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21).
Neuroreport 1994;5(11):1393-6.
1994: Benjamin R; Leake A; Edwardson J A; McKeith I G; Ince P G; Perry R H; Morris C M
Apolipoprotein E genes in Lewy body and Parkinson's disease.
Lancet 1994;343(8912):1565.
1994: McKeith I G; Fairbairn A F; Bothwell R A; Moore P B; Ferrier I N; Thompson P; Perry R H
An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type.
Neurology 1994;44(5):872-7.
1994: Piggott M A; Perry E K; McKeith I G; Marshall E; Perry R H
Dopamine D2 receptors in demented patients with severe neuroleptic sensitivity.
Lancet 1994;343(8904):1044-5.
1994: Hardy J; Crook R; Perry R; Raghavan R; Roberts G
ApoE genotype and Down's syndrome.
Lancet 1994;343(8903):979-80.
1994: Griffiths P D; Perry R H; Crossman A R
A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease.
Neuroscience letters 1994;169(1-2):68-72.
1994: Perry E K; Kerwin J M; Perry R H
On neuronal ill health.
Trends in neurosciences 1994;17(2):51-2.
1994: Davis M; Mendelow A D; Perry R H; Chambers I R; James O F
The effect of age on cerebral oedema, cerebral infarction and neuroprotective potential in experimental occlusive stroke.
Acta neurochirurgica. Supplementum 1994;60():282-4.
1993: Jaros E; Lunec J; Perry R H; Kelly P J; Pearson A D
p53 protein overexpression identifies a group of central primitive neuroectodermal tumours with poor prognosis.
British journal of cancer 1993;68(4):801-7.
1993: Perry E K; Piggott M A; Court J A; Johnson M; Perry R H
Transmitters in the developing and senescent human brain.
Annals of the New York Academy of Sciences 1993;695():69-72.
1993: Court J A; Perry E K; Johnson M; Piggott M A; Kerwin J A; Perry R H; Ince P G
Regional patterns of cholinergic and glutamate activity in the developing and aging human brain.
Brain research. Developmental brain research 1993;74(1):73-82.
1993: Johnson M; Perry E K; Ince P G; Shaw P J; Perry R H
Autoradiographic comparison of the distribution of [3H]MK801 and [3H]CNQX in the human cerebellum during development and aging.
Brain research 1993;615(2):259-66.
1993: Raghavan R; Khin-Nu C; Brown A; Irving D; Ince P G; Day K; Tyrer S P; Perry R H
Detection of Lewy bodies in Trisomy 21 (Down's syndrome).
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1993;20(1):48-51.
1993: Stuart A G; Pearson A D; Emslie J; Lennard A; Davison E V; Perry R H; Crawford P J
Cytogenetic abnormalities in a disseminated medulloblastoma.
Medical and pediatric oncology 1993;21(4):295-8.
1993: Kerwin J M; Morris C M; Johnson M; Perry R H; Perry E K
Hippocampal p75 nerve growth factor receptor immunoreactivity in development, normal aging and senescence.
Acta anatomica 1993;147(4):216-22.
1993: Perry E K; Marshall E; Thompson P; McKeith I G; Collerton D; Fairbairn A F; Ferrier I N; Irving D; Perry R H
Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features.
Journal of neural transmission. Parkinson's disease and dementia section 1993;6(3):167-77.
1992: McKeith I G; Perry R H; Fairbairn A F; Jabeen S; Perry E K
Operational criteria for senile dementia of Lewy body type (SDLT).
Psychological medicine 1992;22(4):911-22.
1992: Dedman D J; Treffry A; Candy J M; Taylor G A; Morris C M; Bloxham C A; Perry R H; Edwardson J A; Harrison P M
Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients.
The Biochemical journal 1992;287 ( Pt 2)():509-14.
1992: Perry E K; Court J A; Johnson M; Piggott M A; Perry R H
Autoradiographic distribution of [3H]nicotine binding in human cortex: relative abundance in subicular complex.
Journal of chemical neuroanatomy 1992;5(5):399-405.
1992: McKeith I; Fairbairn A; Perry R; Thompson P; Perry E
Neuroleptic sensitivity in patients with senile dementia of Lewy body type.
BMJ (Clinical research ed.) 1992;305(6855):673-8.
1992: Jaros E; Perry R H; Adam L; Kelly P J; Crawford P J; Kalbag R M; Mendelow A D; Sengupta R P; Pearson A D
Prognostic implications of p53 protein, epidermal growth factor receptor, and Ki-67 labelling in brain tumours.
British journal of cancer 1992;66(2):373-85.
1992: Kerwin J M; Morris C M; Perry R H; Perry E K
Hippocampal nerve growth factor receptor immunoreactivity in patients with Alzheimer's and Parkinson's disease.
Neuroscience letters 1992;143(1-2):101-4.
1992: Gentleman S M; Williams B; Royston M C; Jagoe R; Clinton J; Perry R H; Ince P G; Allsop D; Polak J M; Roberts G W
Quantification of beta A4 protein deposition in the medial temporal lobe: a comparison of Alzheimer's disease and senile dementia of the Lewy body type.
Neuroscience letters 1992;142(1):9-12.
1992: Piggott M A; Perry E K; Perry R H; Court J A
[3H]MK-801 binding to the NMDA receptor complex, and its modulation in human frontal cortex during development and aging.
Brain research 1992;588(2):277-86.
1992: Gilbertson R J; Jaros E B; Perry R H; Pearson A D
Prognostic factors in medulloblastoma.
Lancet 1992;340(8817):480.
1992: Perry E K; Johnson M; Kerwin J M; Piggott M A; Court J A; Shaw P J; Ince P G; Brown A; Perry R H
Convergent cholinergic activities in aging and Alzheimer's disease.
Neurobiology of aging 1992;13(3):393-400.
1992: Piggott M A; Perry E K; Sahgal A; Perry R H
Examination of parameters influencing [3H]MK-801 binding in postmortem human cortex.
Journal of neurochemistry 1992;58(3):1001-8.
1992: Kerwin J M; Morris C M; Perry R H; Perry E K
Nerve growth factor receptor-like immunoreactivity in the human spinal cord.
Acta anatomica 1992;144(4):348-53.
1991: Ince P; Irving D; MacArthur F; Perry R H
Quantitative neuropathological study of Alzheimer-type pathology in the hippocampus: comparison of senile dementia of Alzheimer type, senile dementia of Lewy body type, Parkinson's disease and non-demented elderly control patients.
Journal of the neurological sciences 1991;106(2):142-52.
1991: Cheng A V; Ferrier I N; Morris C M; Jabeen S; Sahgal A; McKeith I G; Edwardson J A; Perry R H; Perry E K
Cortical serotonin-S2 receptor binding in Lewy body dementia, Alzheimer's and Parkinson's diseases.
Journal of the neurological sciences 1991;106(1):50-5.
1991: Perry E K; Irving D; Perry R H
Cholinergic controversies.
Trends in neurosciences 1991;14(11):483-4; author reply 485-6.
1991: Piggott M A; Candy J M; Perry R H
[3H]nitrendipine binding in temporal cortex in Alzheimer's and Huntington's diseases.
Brain research 1991;565(1):42-7.
1991: Xuereb J H; Perry R H; Candy J M; Perry E K; Marshall E; Bonham J R
Nerve cell loss in the thalamus in Alzheimer's disease and Parkinson's disease.
Brain : a journal of neurology 1991;114 ( Pt 3)():1363-79.
1991: Leake A; Perry E K; Perry R H; Jabeen S; Fairbairn A F; McKeith I G; Ferrier I N
Neocortical concentrations of neuropeptides in senile dementia of the Alzheimer and Lewy body type: comparison with Parkinson's disease and severity correlations.
Biological psychiatry 1991;29(4):357-64.
1991: Kerwin J; Morris C; Oakley A; Perry R; Perry E
Distribution of nerve growth factor receptor immunoreactivity in the human hippocampus.
Neuroscience letters 1991;121(1-2):178-82.
1990: Xuereb J H; Candy J M; Perry E K; Perry R H; Marshall E; Bonham J R
Distribution of neurofibrillary tangle formation and [3H]-D-aspartate receptor binding in the thalamus in the normal elderly brain, in Alzheimer's disease and in Parkinson's disease.
Neuropathology and applied neurobiology 1990;16(6):477-88.
1990: Perry R H; Irving D; Tomlinson B E
Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei.
Journal of the neurological sciences 1990;100(1-2):223-33.
1990: Griffiths P D; Sambrook M A; Perry R; Crossman A R
Changes in benzodiazepine and acetylcholine receptors in the globus pallidus in Parkinson's disease.
Journal of the neurological sciences 1990;100(1-2):131-6.
1990: Xuereb J H; Perry E K; Candy J M; Bonham J R; Perry R H; Marshall E
Parameters of cholinergic neurotransmission in the thalamus in Parkinson's disease and Alzheimer's disease.
Journal of the neurological sciences 1990;99(2-3):185-97.
1990: Leake A; Perry E K; Perry R H; Fairbairn A F; Ferrier I N
Cortical concentrations of corticotropin-releasing hormone and its receptor in Alzheimer type dementia and major depression.
Biological psychiatry 1990;28(7):603-8.
1990: Perry E K; Marshall E; Kerwin J; Smith C J; Jabeen S; Cheng A V; Perry R H
Evidence of a monoaminergic-cholinergic imbalance related to visual hallucinations in Lewy body dementia.
Journal of neurochemistry 1990;55(4):1454-6.
1990: Kerwin J M; Perry E K; Morris C M; Perry R H
Nerve growth factor receptor-positive fibre pathways in the human neocortex.
Biochemical Society transactions 1990;18(4):661-3.
1990: Wariyar U K; Welch R J; Milligan D W; Perry R H
Sonographic and pathological features of callosal hypoplasia in non-ketotic hyperglycinaemia.
Archives of disease in childhood 1990;65(7 Spec No):670-1.
1990: Ghanbari H A; Miller B E; Haigler H J; Arato M; Bissette G; Davies P; Nemeroff C B; Perry E K; Perry R; Ravid R
Biochemical assay of Alzheimer's disease--associated protein(s) in human brain tissue. A clinical study.
JAMA : the journal of the American Medical Association 1990;263(21):2907-10.
1990: Narang H K; Perry R H
Diagnosis of Creutzfeldt-Jakob disease by electron microscopy.
Lancet 1990;335(8690):663-4.
1990: Perry R H; Irving D; Blessed G; Fairbairn A; Perry E K
Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly.
Journal of the neurological sciences 1990;95(2):119-39.
1990: Perry E K; Kerwin J; Perry R H; Blessed G; Fairbairn A F
Visual hallucinations and the cholinergic system in dementia.
Journal of neurology, neurosurgery, and psychiatry 1990;53(1):88.
1990: Perry E K; Marshall E; Perry R H; Irving D; Smith C J; Blessed G; Fairbairn A F
Cholinergic and dopaminergic activities in senile dementia of Lewy body type.
Alzheimer disease and associated disorders 1990;4(2):87-95.
1990: Perry R H; Irving D; Blessed G; Perry E K; Smith C J; Fairbairn A F
Dementia in old age: identification of a clinically and pathologically distinct disease category.
Advances in neurology 1990;51():41-6.
1990: Perry E K; Smith C J; Court J A; Perry R H
Cholinergic nicotinic and muscarinic receptors in dementia of Alzheimer, Parkinson and Lewy body types.
Journal of neural transmission. Parkinson's disease and dementia section 1990;2(3):149-58.
1990: Xuereb J H; Tomlinson B E; Irving D; Perry R H; Blessed G; Perry E K
Cortical and subcortical pathology in Parkinson's disease: relationship to parkinsonian dementia.
Advances in neurology 1990;53():35-40.
1989: Johnson M; Perry R H; Charlton F G; Moses M A; Court J A; Perry E K
Distribution of [3H]MK801 binding in the normal aged human hippocampus.
Brain research 1989;499(1):184-7.
1989: Perry E K; Perry R
Amyloid and Alzheimer's disease: a question of specificity.
Neurobiology of aging 1989;10(5):473-4; discussion 477-8.
1989: Perry E K; Smith C J; Perry R H; Whitford C; Johnson M; Birdsall N J
Regional distribution of muscarinic and nicotinic cholinergic receptor binding activities in the human brain.
Journal of chemical neuroanatomy 1989;2(4):189-99.
1989: Perry R H; Irving D; Blessed G; Perry E K; Fairbairn A F
Senile dementia of Lewy body type and spectrum of Lewy body disease.
Lancet 1989;1(8646):1088.
1989: Mantle D; Lauffart B; Perry E K; Perry R H
Comparison of major cortical aminopeptidase activity in normal brain and brain from patients with Alzheimer's disease.
Journal of the neurological sciences 1989;89(2-3):227-34.
1989: Perry R H; Irving D; Blessed G; Perry E K; Fairbairn A F
Clinically and neuropathologically distinct form of dementia in the elderly.
Lancet 1989;1(8630):166.
1988: Bown N P; Pearson A D; Davison E V; Gardner-Medwin D; Crawford P; Perry R
Multiple chromosome rearrangements in a childhood ependymoma.
Cancer genetics and cytogenetics 1988;36(1):25-30.
1988: Whitford C; Candy J; Edwardson J; Perry R
Cortical somatostatinergic system not affected in Alzheimer's and Parkinson's diseases.
Journal of the neurological sciences 1988;86(1):13-8.
1988: Smith C J; Perry E K; Perry R H; Candy J M; Johnson M; Bonham J R; Dick D J; Fairbairn A; Blessed G; Birdsall N J
Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders.
Journal of neurochemistry 1988;50(3):847-56.
1987: Smith C J; Perry E K; Perry R H; Fairbairn A F; Birdsall N J
Guanine nucleotide modulation of muscarinic cholinergic receptor binding in postmortem human brain--a preliminary study in Alzheimer's disease.
Neuroscience letters 1987;82(2):227-32.
1987: Charlton B G; Ferrier I N; Perry R H
Distribution of corticotropin-releasing factor-like immunoreactivity in human brain.
Neuropeptides 1987;10(4):329-34.
1987: Court J A; McDermott J R; Gibson A M; Marshall E; Bloxham C A; Perry R H; Edwardson J A
Raised thyrotrophin-releasing hormone, pyroglutamylamino peptidase, and proline endopeptidase are present in the spinal cord of wobbler mice but not in human motor neurone disease.
Journal of neurochemistry 1987;49(4):1084-90.
1987: Court J; Ferrier N; Griffiths H; Lauffart B; Perry R; Candy J; Fairbairn A; Blessed G
Serum creatine kinase-BB levels and cerebral cortical creatine kinase activity in senile dementia of the Alzheimer type.
Journal of the neurological sciences 1987;80(1):111-5.
1987: Cross A J; Slater P; Simpson M; Royston C; Deakin J F; Perry R H; Perry E K
Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases.
Neuroscience letters 1987;79(1-2):213-7.
1987: McKeith I G; Marshall E F; Ferrier I N; Armstrong M M; Kennedy W N; Perry R H; Perry E K; Eccleston D
5-HT receptor binding in post-mortem brain from patients with affective disorder.
Journal of affective disorders 1987;13(1):67-74.
1987: Atack J R; Perry E K; Bonham J R; Perry R H
Molecular forms of acetylcholinesterase and butyrylcholinesterase in human plasma and cerebrospinal fluid.
Journal of neurochemistry 1987;48(6):1845-50.
1987: Atack J R; Perry E K; Bonham J R; Candy J M; Perry R H
Molecular forms of butyrylcholinesterase in the human neocortex during development and degeneration of the cortical cholinergic system.
Journal of neurochemistry 1987;48(6):1687-92.
1987: Perry E K; Perry R H; Smith C J; Dick D J; Candy J M; Edwardson J A; Fairbairn A; Blessed G
Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases.
Journal of neurology, neurosurgery, and psychiatry 1987;50(6):806-9.
1987: Taylor G R; Carter G I; Crow T J; Johnson J A; Fairbairn A F; Perry E K; Perry R H
Recovery and measurement of RNA in Alzheimer's disease by molecular hybridisation.
Journal of neurology, neurosurgery, and psychiatry 1987;50(3):356.
1987: Perry R H; Perry E K; Smith C J; Xuereb J H; Irving D; Whitford C A; Candy J M; Cross A J
Cortical neuropathological and neurochemical substrates of Alzheimer's and Parkinson's diseases.
Journal of neural transmission. Supplementum 1987;24():131-6.
1986: Perry E K; Perry R H; Smith C J; Purohit D; Bonham J; Dick D J; Candy J M; Edwardson J A; Fairbairn A
Cholinergic receptors in cognitive disorders.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 1986;13(4 Suppl):521-7.
1986: Perry E K; Smith C J; Atack J R; Candy J M; Johnson M; Perry R H
Neocortical cholinergic enzyme and receptor activities in the human fetal brain.
Journal of neurochemistry 1986;47(4):1262-9.
1986: Bateman D E; McDermott J R; Perry R H; Dimaline R; Biggins J A; Edwardson J A
Neuropeptides in gliomas: identification of somatostatin 14 in a medulloblastoma.
Journal of neurology, neurosurgery, and psychiatry 1986;49(9):1074-6.
1986: Uney J B; Marchbanks R M; Reynolds G P; Perry R H
Lithium prophylaxis inhibits choline transport in post-mortem brain.
Lancet 1986;2(8504):458.
1986: Atack J R; Perry E K; Bonham J R; Candy J M; Perry R H
Molecular forms of acetylcholinesterase and butyrylcholinesterase in the aged human central nervous system.
Journal of neurochemistry 1986;47(1):263-77.
1986: Candy J M; Oakley A E; Klinowski J; Carpenter T A; Perry R H; Atack J R; Perry E K; Blessed G; Fairbairn A; Edwardson J A
Aluminosilicates and senile plaque formation in Alzheimer's disease.
Lancet 1986;1(8477):354-7.
1986: Taylor G R; Carter G I; Crow T J; Johnson J A; Fairbairn A F; Perry E K; Perry R H
Recovery and measurement of specific RNA species from postmortem brain tissue: a general reduction in Alzheimer's disease detected by molecular hybridization.
Experimental and molecular pathology 1986;44(1):111-6.
1986: Perry R H
Recent advances in neuropathology.
British medical bulletin 1986;42(1):34-41.
1986: Edwardson J A; Klinowski J; Oakley A E; Perry R H; Candy J M
Aluminosilicates and the ageing brain: implications for the pathogenesis of Alzheimer's disease.
Ciba Foundation symposium 1986;121():160-79.
1986: Candy J M; Perry E K; Perry R H; Court J A; Oakley A E; Edwardson J A
The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease.
Progress in brain research 1986;70():105-32.
1986: Ferrier I N; McKeith I G; Cross A J; Perry E K; Candy J M; Perry R H
Postmortem neurochemical studies in depression.
Annals of the New York Academy of Sciences 1986;487():128-42.
1985: Candy J M; Gascoigne A D; Biggins J A; Smith A I; Perry R H; Perry E K; McDermott J R; Edwardson J A
Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease.
Journal of the neurological sciences 1985;71(2-3):315-23.
1985: Candy J M; Perry E K; Perry R H; Bloxham C A; Thompson J; Johnson M; Oakley A E; Edwardson J A
Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus.
Neuroscience letters 1985;61(1-2):91-5.
1985: Atack J R; Perry E K; Perry R H; Wilson I D; Bober M J; Blessed G; Tomlinson B E
Blood acetyl- and butyrylcholinesterases in senile dementia of Alzheimer type.
Journal of the neurological sciences 1985;70(1):1-12.
1985: Perry E K; Curtis M; Dick D J; Candy J M; Atack J R; Bloxham C A; Blessed G; Fairbairn A; Tomlinson B E; Perry R H
Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease.
Journal of neurology, neurosurgery, and psychiatry 1985;48(5):413-21.
1985: Candy J M; Perry R H; Thompson J E; Johnson M; Oakley A E
Neuropeptide localisation in the substantia innominata and adjacent regions of the human brain.
Journal of anatomy 1985;140 ( Pt 2)():309-27.
1985: Perry E K; Perry R H
A review of neuropathological and neurochemical correlates of Alzheimer's disease.
Danish medical bulletin 1985;32 Suppl 1():27-34.
1985: Wester P; Bateman D E; Dodd P R; Edwardson J A; Hardy J A; Kidd A M; Perry R H; Singh G B
Agonal status affects the metabolic activity of nerve endings isolated from postmortem human brain.
Neurochemical pathology 1985;3(3):169-80.
1984: Perry E K; Perry R H; Candy J M; Fairbairn A F; Blessed G; Dick D J; Tomlinson B E
Cortical serotonin-S2 receptor binding abnormalities in patients with Alzheimer's disease: comparisons with Parkinson's disease.
Neuroscience letters 1984;51(3):353-7.
1984: Biggins J A; McDermott J R; Smith A I; Candy J M; Perry R H; Bateman D E; Edwardson J A
Chromatographic characterization of neuropeptides in post mortem human brain.
Journal of the neurological sciences 1984;66(1):47-58.
1984: Perry R H; Candy J M; Perry E K; Thompson J; Oakley A E
The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations.
Journal of anatomy 1984;138 ( Pt 4)():713-32.
1984: Cross A J; Crow T J; Johnson J A; Perry E K; Perry R H; Blessed G; Tomlinson B E
Studies on neurotransmitter receptor systems in neocortex and hippocampus in senile dementia of the Alzheimer-type.
Journal of the neurological sciences 1984;64(2):109-17.
1984: Perry E K; Atack J R; Perry R H; Hardy J A; Dodd P R; Edwardson J A; Blessed G; Tomlinson B E; Fairbairn A F
Intralaminar neurochemical distributions in human midtemporal cortex: comparison between Alzheimer's disease and the normal.
Journal of neurochemistry 1984;42(5):1402-10.
1983: Perry E K; Perry R H
Human brain neurochemistry - some postmortem problems.
Life sciences 1983;33(18):1733-43.
1983: Perry R H; Tomlinson B E; Candy J M; Blessed G; Foster J F; Bloxham C A; Perry E R
Cortical cholinergic deficit in mentally impaired Parkinsonian patients.
Lancet 1983;2(8353):789-90.
1983: Atack J R; Perry E K; Bonham J R; Perry R H; Tomlinson B E; Blessed G; Fairbairn A
Molecular forms of acetylcholinesterase in senile dementia of Alzheimer type: selective loss of the intermediate (10S) form.
Neuroscience letters 1983;40(2):199-204.
1983: Cross A J; Crow T J; Johnson J A; Joseph M H; Perry E K; Perry R H; Blessed G; Tomlinson B E
Monoamine metabolism in senile dementia of Alzheimer type.
Journal of the neurological sciences 1983;60(3):383-92.
1983: Candy J M; Perry R H; Perry E K; Irving D; Blessed G; Fairbairn A F; Tomlinson B E
Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases.
Journal of the neurological sciences 1983;59(2):277-89.
1983: Hardy J A; Dodd P R; Oakley A E; Perry R H; Edwardson J A; Kidd A M
Metabolically active synaptosomes can be prepared from frozen rat and human brain.
Journal of neurochemistry 1983;40(3):608-14.
1983: Perry E K; Marshall E F; Blessed G; Tomlinson B E; Perry R H
Decreased imipramine binding in the brains of patients with depressive illness.
The British journal of psychiatry : the journal of mental science 1983;142():188-92.
1983: Biggins J A; Perry E K; McDermott J R; Smith A I; Perry R H; Edwardson J A
Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression.
Journal of the neurological sciences 1983;58(1):117-22.
1982: Perry R H; Candy J M; Perry E K; Irving D; Blessed G; Fairbairn A F; Tomlinson B E
Extensive loss of choline acetyltransferase activity is not reflected by neuronal loss in the nucleus of Meynert in Alzheimer's disease.
Neuroscience letters 1982;33(3):311-5.
1982: Hardy J A; Dodd P R; Oakley A E; Kidd A M; Perry R H; Edwardson J A
Use of post-mortem human synaptosomes for studies of metabolism and transmitter amino acid release.
Neuroscience letters 1982;33(3):317-22.
1982: Perry E K; Perry R H; Tomlinson B E
The influence of agonal status on some neurochemical activities of postmortem human brain tissue.
Neuroscience letters 1982;29(3):303-7.
1982: Perry R H; Wilson I D; Bober M J; Atack J; Blessed G; Tomlinson B E; Perry E K
Plasma and erythrocyte acetylcholinesterase in senile dementia of Alzheimer type.
Lancet 1982;1(8264):174-5.
1982: Perry E K; Perry R H
Neurotransmitter and neuropeptide systems in Alzheimer-type dementia.
Experimental brain research. Experimentelle Hirnforschung. Expérimentation cérébrale 1982;Suppl 5():140-5.
1981: Perry R H; Dockray G J; Dimaline R; Perry E K; Blessed G; Tomlinson B E
Neuropeptides in Alzheimer's disease, depression and schizophrenia. A post mortem analysis of vasoactive intestinal peptide and cholecystokinin in cerebral cortex.
Journal of the neurological sciences 1981;51(3):465-72.
1981: Perry E K; Oakley A E; Candy J M; Perry R H
Properties and possible significance of substance P and insulin fibrils.
Neuroscience letters 1981;25(3):321-5.
1981: Perry E K; Tomlinson B E; Blessed G; Perry R H; Cross A J; Crow T J
Neuropathological and biochemical observations on the noradrenergic system in Alzheimer's disease.
Journal of the neurological sciences 1981;51(2):279-87.
1981: Perry E K; Tomlinson B E; Blessed G; Perry R H; Cross A J; Crow T T
Noradrenergic and cholinergic systems in senile dementia of Alzheimer type.
Lancet 1981;2(8238):149.
1981: Cross A J; Crow T J; Perry E K; Perry R H; Blessed G; Tomlinson B E
Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease.
British medical journal (Clinical research ed.) 1981;282(6258):93-4.
1981: Perry E K; Blessed G; Tomlinson B E; Perry R H; Crow T J; Cross A J; Dockray G J; Dimaline R; Arregui A
Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes.
Neurobiology of aging 1981;2(4):251-6.
1980: Tarbit I; Perry E K; Perry R H; Blessed G; Tomlinson B E
Hippocampal free amino acids in Alzheimer's disease.
Journal of neurochemistry 1980;35(5):1246-9.
1980: Perry E K; Perry R H; Tomlinson B E; Blessed G; Gibson P H
Coenzyme A-acetylating enzymes in Alzheimer's disease: possible cholinergic 'compartment' of pyruvate dehydrogenase.
Neuroscience letters 1980;18(1):105-10.
1980: Perry R H; Blessed G; Perry E K; Tomlinson B E
Histochemical observations on cholinesterase activities in the brains of elderly normal and demented (Alzheimer-type) patients.
Age and ageing 1980;9(1):9-16.
1979: Tomlinson B E; Perry R H; Stewart-Wynne E G
Influence of site of origin of lung carcinomas on clinical presentation and central nervous system metastases.
Journal of neurology, neurosurgery, and psychiatry 1979;42(1):82-8.
1978: Perry E K; Tomlinson B E; Blessed G; Bergmann K; Gibson P H; Perry R H
Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia.
British medical journal 1978;2(6150):1457-9.
1978: Perry E K; Perry R H; Blessed G; Tomlinson B E
Changes in brain cholinesterases in senile dementia of Alzheimer type.
Neuropathology and applied neurobiology 1978;4(4):273-7.
1977: Perry E K; Gibson P H; Blessed G; Perry R H; Tomlinson B E
Neurotransmitter enzyme abnormalities in senile dementia. Choline acetyltransferase and glutamic acid decarboxylase activities in necropsy brain tissue.
Journal of the neurological sciences 1977;34(2):247-65.
1977: Perry E K; Perry R H; Gibson P H; Blessed G; Tomlinson B E
A cholinergic connection between normal aging and senile dementia in the human hippocampus.
Neuroscience letters 1977;6(1):85-9.
1977: Perry E K; Perry R H; Taylor M J; Tomlinson B E
Evidence of a circadian fluctuation in neurotransmitter enzyme activities measured in autopsy human brain.
Journal of neurochemistry 1977;29(3):593-4.
1977: Perry E K; Perry R H; Tomlinson B E
Dietary lecithin supplements in dementia of Alzheimer type.
Lancet 1977;2(8031):242-3.
1977: Perry E K; Perry R H; Taylor M J; Tomlinson B E
Circadian variation in human brain enzymes.
Lancet 1977;1(8014):753-4.
1977: Perry E K; Perry R H; Tomlinson B E
Circadian variations in cholinergic enzymes and muscarinic receptor binding in human cerebral cortex.
Neuroscience letters 1977;4(3-4):185-9.
1977: Perry E K; Perry R H; Blessed G; Tomlinson B E
Necropsy evidence of central cholinergic deficits in senile dementia.
Lancet 1977;1(8004):189.
1977: Perry R H; Tomlinson B E; Taylor M J; Perry E K
Human brain temperature at necropsy: a guide in post-mortem biochemistry.
Lancet 1977;1(8001):38.
1975: Ramani P S; Perry R H; Tomlinson B E
Role of ligamentum flavum in the symptomatology of prolapsed lumbar intervertebral discs.
Journal of neurology, neurosurgery, and psychiatry 1975;38(6):550-7.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Robert Perry

Research Profile (preview)

Disorders

Anatomy

Chemicals & Drugs

Procedures

Genes & Molecular Sequences

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Robert Perry (preview)

All Publications